Toronto Stock Exchange Symbol: DND
MISSISSAUGA, ON, Jan. 3, 2013 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND)
(OTC: CPHMF), announced today that Larry Andrews, President and Chief
Executive Officer, is presenting at Biotech Showcase™ 2013, which is being
held in San Francisco at the Wyndham Parc 55 Hotel at Union Square. Mr.
Andrews will provide a corporate update on Monday, January 7, 2013 at 1:45 PM
PST in the Powell Room, followed immediately by Q&A breakout session in the
To learn more about Biotech Showcase™ 2013 please visit their website
Cipher's presentation will be available on their website www.cipherpharma.com.
About Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals (TSX: DND; OTC: CPHMF) is a growing specialty
pharmaceutical company that commercializes novel formulations of successful,
currently marketed molecules. Cipher's strategy is to in-license clearly
differentiated products, advance them through the clinical development and
regulatory approval stages, and out-license to international marketing
partners. Cipher's first product is a fenofibrate formulation marketed in the
United States as Lipofen®. Cipher's second product, an extended-release
tramadol, is marketed in the United States as ConZip® and in Canada as
Durela®. Cipher's third product, a novel formulation of the acne treatment
isotretinoin, was approved by the FDA in May and was launched in the United
States in Q4 2012 as Absorica™. The product was also recently approved by
Health Canada and Cipher expects to launch it as Epuris™ in Canada in Q2
For more information, please visit www.cipherpharma.com.
Craig Armitage Investor Relations The Equicom Group (416) 815-0700 ext 278
(416)815-0080 fax email@example.com
Larry Andrews President and CEO Cipher Pharmaceuticals (905) 602-5840 ext 324
(905) 602-0628 fax firstname.lastname@example.org
SOURCE: Cipher Pharmaceuticals Inc.
To view this news release in HTML formatting, please use the following URL:
CO: Cipher Pharmaceuticals Inc.
NI: MTC HEA SHOW NP
Press spacebar to pause and continue. Press esc to stop.